Hacking group FulcrumSec has claimed responsibility for a breach of the systems of Danish pharmaceutical giant Novo Nordisk, saying it was exploring selling stolen data after a failed ransom demand.
Novo Nordisk, known for weight-loss drugs such as Ozempic and Wegovy, disclosed the hack late last week, saying attackers had stolen data associated with clinical trials.
It said the data was pseudonymised and could not be linked to patients by name or identifiers.
Anonymised data
“Knowledge of patient identity would require access to further information, which was not part of the incident,” the firm said.
